Abbott Laboratories (ABT)

122.25
0.04 0.03
NYSE
Prev Close 122.21
Open 122.21
Day Low/High 121.19 / 122.79
52 Wk Low/High 61.61 / 115.14
Volume 1.01M
Exchange NYSE
Shares Outstanding 1771.53B
Market Cap 212.19B
P/E Ratio 60.02
Div & Yield N.A. (N.A)
Charts Emit a Yellow 'Caution' Signal

Charts Emit a Yellow 'Caution' Signal

The signs that have warned of a possible market reversal only have become more extreme.

Trending Tickers: SWN, ABT, AAL, UAL, EW

Oil began to rebound Wednesday from steep declines earlier this week.

Traders, Here's Your 'Short' Notice

Traders, Here's Your 'Short' Notice

They should wait until the rally appears to be running out of steam in order to go in on the short side.

Cramer: Worst May Be Over for Embattled Pharma

The M&A activity is an incredible and a welcome sign.

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. stocks dropped on Thursday, as first quarter gross domestic product came in weaker than expected.

Even the Fed Can't Make Stocks Budge

Even the Fed Can't Make Stocks Budge

Movement has become difficult after weeks of advances, which suggests a downturn may be near.

Jim Cramer Says You Want to Own This Health Care Stock

Jim Cramer Says You Want to Own This Health Care Stock

Jim Cramer believes Abbott Labs' CEO Miles White is doing a terrific job of making the company better.

Stericycle Is a Good Shorting Candidate

Stericycle Is a Good Shorting Candidate

This stock is well into overbought territory.

Small-Cap 'Mutiny' Spells Trouble

Small-Cap 'Mutiny' Spells Trouble

The Russell 2000's failure to follow the S&P and Dow's lead is only one reason for concern.

Alere's Stock Spikes Following News of Its Impending Buy by Abbott

Alere's Stock Spikes Following News of Its Impending Buy by Abbott

Shares of Alere soared on Monday on word that Abbott Labs would acquire the company in a deal valued at $7.9 billion.

Abbott downgraded at William Blair

Health Care Stocks Are Getting 'Uber-ed' by Ashton Kutcher

Health Care Stocks Are Getting 'Uber-ed' by Ashton Kutcher

Two significant, but subtle forces may threaten the group in the next 12 months.

Cramer: Dow Chemical-DuPont Merger Will Instantly Create Value

Cramer: Dow Chemical-DuPont Merger Will Instantly Create Value

The merged company can become multiple companies.

Abbott Labs upgraded at Jefferies

Don't Abandon the Biotech Ship

Don't Abandon the Biotech Ship

There's too much good out there.

Abbott downgraded at Goldman

The Book of Boockvar

Peter Boockvar looks at China, the European Central Bank and the Bank of Japan this morning: "According to the Chinese, their economy grew 6.9% y/o/y in the third quarter vs. 7% in the second quarter and vs. a 6.8% estimate. While we'll take that wi...

Abbott upgraded at Barclays

Drug Stocks' Earnings Power Won't Go Away

Before you sell them, ask yourself at what multiple you sell.

AbbVie Has More Downside to Go

AbbVie Has More Downside to Go

The stock has shown awful relative strength.

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.

Market Wrap: IBM and United Tech a Real Drag

Market Wrap: IBM and United Tech a Real Drag

IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..

The Stock Market Is Treacherous, Perilous, and Ultra-Rewarding

The Stock Market Is Treacherous, Perilous, and Ultra-Rewarding

This market is almost entirely special situation.

3 Dividend Hikes This Week You Should Know About

3 Dividend Hikes This Week You Should Know About

Duke Energy's recent increase puts its payout at the high end of the industry range.

Obamacare Ruling Means the Debate Is Over

Obamacare Ruling Means the Debate Is Over

As health-care stocks rally, it's time for politicians to move on.

AbbVie Is Knocking on the Door Again

AbbVie Is Knocking on the Door Again

The ABBV chart looks constructive, with solid volume and bullish indicators.

Charter Communications Hopes to Succeed Where Comcast Didn't

Charter Communications Hopes to Succeed Where Comcast Didn't

Durable Goods orders fell a half percent in April matching estimates.

The Second-Strongest Stock Market Sector Doesn't Jibe With the Strongest

The Second-Strongest Stock Market Sector Doesn't Jibe With the Strongest

You could throw darts at financials and health care and win. 

ABT Investor Mtg.